APA (7th ed.) Citation

P, Z., K, B., J, L., E, Y., T, P., S, B., . . . D, L. (2012). MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling. Cancer research, 72(7), 1751. https://doi.org/10.1158/0008-5472.CAN-11-3027

Chicago Style (17th ed.) Citation

P, Zhang, et al. "MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1α and Enhances β-catenin Signaling." Cancer Research 72, no. 7 (2012): 1751. https://doi.org/10.1158/0008-5472.CAN-11-3027.

MLA (9th ed.) Citation

P, Zhang, et al. "MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1α and Enhances β-catenin Signaling." Cancer Research, vol. 72, no. 7, 2012, p. 1751, https://doi.org/10.1158/0008-5472.CAN-11-3027.